# FDA Inspection 1162363 - Octapharma Plasma Inc - February 14, 2022

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/4b85898a-2a51-4d57-af25-b133affd69be
Source feed: FDA_Inspections

> FDA Inspection 1162363 for Octapharma Plasma Inc on February 14, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1162363
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2022-02-14
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1162363 - 2022-02-14](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/d3b7d1a3-b38a-4c63-92ca-a5e92822d436)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/20026757-6d89-423b-9978-7b47ddf2ba80

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d